Testing effectiveness (Phase 2)Study completedNCT00063414
What this trial is testing
ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis
Who this might be right for
Ulcerative Colitis
Ionis Pharmaceuticals, Inc.